Doubled sales and positive earnings for the first quarter
First quarter · Net sales reached SEK 26.8 (13.3) million. · Result after tax came in at SEK 0.7 (-12.2) million. · Earnings per share, basic and diluted, were SEK 0.01 (-0.09). · Cash and cash equivalents were SEK 33.9 (53.9) million. Significant events in Q1 · Enzymatica doubled sales during the quarter driven by extremely strong orders in March as a result of the coronavirus outbreak. This is also the first single profitable quarter for Enzymatica. · Enzymatica signed an exclusive 7-year agreement with Keyuan Xinhai (Beijing) Medical